Corbion announces strong first quarter 2025 results, well on track to deliver full-year outlook
23 April 2025 - 7:00AM
UK Regulatory
Corbion announces strong first quarter 2025 results, well on track
to deliver full-year outlook
|
DATE |
|
23 April 2025 |
|
|
|
Corbion Q1 2025 Interim Management Statement |
|
|
|
|
Corbion announces strong first quarter 2025 result, well on
track to deliver full-year outlook
Corbion, the Amsterdam-listed sustainable ingredients company
that champions preservation through application of science, today
publishes its results for Q1 2025 ending 31 March.
| Key
highlights Q1 2025: |
|
• Organic sales growth: |
+7.9% |
|
|
ο Volume/mix: |
+8.4% |
|
|
ο Price: |
-0.5% |
|
• Sales: € 329.7 million |
|
• Adjusted EBITDA: € 54.4 million, an
organic increase of +53.9% |
|
• Operating profit: € 34.0 million,
an organic increase of +186% |
|
• FY 2025 outlook affirmed |
|
€ million |
Q1 2025 |
|
Q1 20241 |
|
|
Total growth |
|
Organic growth |
|
|
Sales |
329.7 |
|
300.4 |
|
|
+9.8% |
|
+7.9% |
|
|
Adjusted EBITDA |
54.4 |
|
34.5 |
|
|
+57.7% |
|
+53.9% |
|
|
Adjusted EBITDA margin (%) |
16.5% |
|
11.5% |
|
|
|
|
|
|
|
Operating Profit |
34.0 |
|
11.6 |
|
|
+193.1% |
|
186.2% |
|
Commenting on today’s results, Olivier Rigaud, CEO, stated:
“Corbion had an excellent start to 2025. I am pleased to report on
this strong quarter with positive volume/mix and organic Adjusted
EBITDA growth, as well as positive free cash flow. Corbion provides
essential, natural solutions to meet customers’ preservation and
nutrition needs, and the Q1 results highlight the resilience of our
businesses.
In Functional Ingredients & Solutions, we delivered
volume/mix growth in all three businesses (Food, Biochemicals, and
Lactic acid to the PLA JV), and we are seeing the results of our
efficiency and cost-management measures translating into improved
margins to greater than 12%.
In Health & Nutrition, we delivered volume/mix growth across
all three businesses (Nutrition, Biomedical polymers, and Pharma),
with Adjusted EBITDA margins exceeding 30% for the business unit
overall.
As we navigate the macro-economic and geopolitical uncertainty,
we continue to execute on our strategy and remain on track to
deliver our 2025 guidance on all forecasted metrics, including
volume/mix, Adjusted EBITDA, and free cash flow.”
________________________
1 Q1 2024 values are presented as continued
operations in all tables
- 2025-04-23_Corbion_Press release_Q1 2025
Corbion N.V (TG:CSUA)
Historical Stock Chart
Von Mai 2025 bis Jun 2025
Corbion N.V (TG:CSUA)
Historical Stock Chart
Von Jun 2024 bis Jun 2025
